Integra LifeSciences Holdings Corporation Company Profile (NASDAQ:IART)

About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation logoIntegra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing and marketing of surgical implants and medical instruments. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery. Its segments include Specialty Surgical Solutions, which offers products, including specialty surgical instrumentation for a range of specialties. Its product category includes products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care, including product portfolios used in neurosurgery operation suites and critical care units, and Orthopedics and Tissue Technologies, which offers products of a combination of differentiated regenerative technology products for soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement hardware products for both upper extremities and lower extremities.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Instruments & Supplies
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: IART
  • CUSIP: 45798520
Key Metrics:
  • Previous Close: $42.02
  • 50 Day Moving Average: $42.67
  • 200 Day Moving Average: $72.43
  • 52-Week Range: $28.55 - $45.87
  • Trailing P/E Ratio: 55.12
  • Foreward P/E Ratio: 19.15
  • P/E Growth: 1.90
  • Market Cap: $3.17B
  • Outstanding Shares: 74,771,000
  • Beta: 0.8
Profitability:
  • Net Margins: 6.09%
  • Return on Equity: 16.11%
  • Return on Assets: 7.00%
Debt:
  • Debt-to-Equity Ratio: 0.80%
  • Current Ratio: 3.17%
  • Quick Ratio: 1.81%
Additional Links:
Companies Related to Integra LifeSciences Holdings Corporation:

Analyst Ratings

Consensus Ratings for Integra LifeSciences Holdings Corporation (NASDAQ:IART) (?)
Ratings Breakdown: 3 Hold Ratings, 7 Buy Ratings
Consensus Rating:Buy (Score: 2.70)
Consensus Price Target: $47.06 (11.16% upside)

Analysts' Ratings History for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Show:
DateFirmActionRatingPrice TargetDetails
1/13/2017Barclays PLCReiterated RatingEqual Weight$84.00 -> $42.00View Rating Details
1/13/2017RBC Capital MarketsReiterated RatingSector Perform$85.00 -> $46.00View Rating Details
1/13/2017Royal Bank of CanadaLower Price TargetSector Perform$85.00 -> $46.00View Rating Details
1/11/2017Oppenheimer Holdings, Inc.Reiterated RatingBuyView Rating Details
1/6/2017JMP SecuritiesUpgradeMarket Perform -> Outperform$50.00View Rating Details
10/28/2016Lake Street CapitalUpgradeHold -> Buy$46.00View Rating Details
9/27/2016Jefferies Group LLCReiterated RatingBuy$47.50View Rating Details
9/23/2016ArgusBoost Price TargetBuy$45.00 -> $52.50View Rating Details
8/21/2016Piper Jaffray CompaniesReiterated RatingOverweight$43.00 -> $47.00View Rating Details
7/13/2016J P Morgan Chase & CoInitiated CoverageOverweightView Rating Details
11/12/2015Citigroup Inc.Initiated CoverageBuy$37.50View Rating Details
9/21/2015Bank of America CorpUpgradeNeutral -> Buy$36.00 -> $39.50View Rating Details
7/29/2015Raymond James Financial, Inc.UpgradeMarket Perform -> OutperformView Rating Details
5/1/2015Wells Fargo & CoUpgradeMarket Perform -> OutperformView Rating Details
(Data available from 2/25/2015 forward)

Earnings

Earnings History for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/25/2017        
2/23/2017Q4 2016$0.52$0.52$257.27 million$255.70 millionViewN/AView Earnings Details
10/27/2016Q3$0.89$0.93$249.30 million$250.30 millionViewListenView Earnings Details
7/28/2016Q216$0.76$0.79$243.17 million$249.30 millionViewListenView Earnings Details
4/27/2016Q116$0.73$0.74$230.66 million$236.80 millionViewListenView Earnings Details
2/25/2016Q4$0.86$0.87$241.11 million$241.20 millionViewListenView Earnings Details
11/3/2015Q315$0.74$0.75$224.08 million$226.40 millionViewListenView Earnings Details
7/30/2015Q215$0.75$0.79$239.91 million$244.10 millionViewListenView Earnings Details
4/30/2015Q115$0.63$0.76$229.69 million$233.70 millionViewN/AView Earnings Details
2/24/2015Q414$0.89$0.94$244.39 million$252.20 millionViewListenView Earnings Details
11/3/2014Q314$0.74$0.76$233.50 million$229.70 millionViewListenView Earnings Details
8/5/2014Q214$0.64$0.68$229.32 million$231.40 millionViewN/AView Earnings Details
5/1/2014Q114$0.58$0.57$213.30 million$215.00 millionViewN/AView Earnings Details
2/25/2014Q413$0.81$0.78$223.37 million$220.80 millionViewN/AView Earnings Details
10/28/2013Q313$0.70$0.72$214.05 million$213.20 millionViewN/AView Earnings Details
8/1/2013Q2 2013$0.55$0.60$207.30 million$205.50 millionViewN/AView Earnings Details
5/2/2013Q1 2013$0.37$0.39$195.20 million$196.70 millionViewN/AView Earnings Details
2/21/2013Q4 2012$0.76$0.78$215.90 million$214.40 millionViewN/AView Earnings Details
10/24/2012$0.77$0.85ViewN/AView Earnings Details
7/26/2012$0.69$0.74ViewN/AView Earnings Details
4/25/2012$0.60$0.71ViewN/AView Earnings Details
2/23/2012$0.55$0.72ViewN/AView Earnings Details
10/31/2011$0.77$0.77ViewN/AView Earnings Details
7/28/2011$0.61$0.70ViewN/AView Earnings Details
4/28/2011$0.66$0.66ViewN/AView Earnings Details
2/24/2011$0.73$0.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Current Year EPS Consensus Estimate: $1.93 EPS
Next Year EPS Consensus Estimate: $2.21 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20167$0.72$0.85$0.78
Q2 20164$0.76$0.85$0.80
Q3 20164$0.87$0.92$0.89
Q4 20164$0.52$1.05$0.91
Q1 20174$0.38$0.98$0.65
Q2 20174$0.45$0.90$0.66
Q3 20174$0.50$0.98$0.71
Q4 20174$0.56$0.96$0.67
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
Insider Ownership Percentage: 21.40%
Institutional Ownership Percentage: 44.37%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/8/2016Peter J ArduiniCEOSell24,009$79.51$1,908,955.59View SEC Filing  
8/23/2016Raymond G MurphyDirectorSell2,600$86.64$225,264.00View SEC Filing  
8/9/2016Peter J ArduiniCEOSell24,009$84.52$2,029,240.68View SEC Filing  
8/4/2016Raymond G MurphyDirectorSell2,610$84.83$221,406.30View SEC Filing  
8/1/2016Richard D GorelickVPSell4,000$84.60$338,400.00View SEC Filing  
5/9/2016Joseph VinhaisVPSell972$73.36$71,305.92View SEC Filing  
5/4/2016Glenn ColemanCFOSell3,563$70.62$251,619.06View SEC Filing  
5/3/2016Christian S SchadeDirectorSell7,829$70.42$551,318.18View SEC Filing  
5/2/2016Daniel L ReuversVPSell1,000$71.43$71,430.00View SEC Filing  
4/29/2016Richard D GorelickVPSell4,000$70.72$282,880.00View SEC Filing  
4/27/2016Stuart EssigDirectorSell104,390$70.15$7,322,958.50View SEC Filing  
4/6/2016Stuart EssigDirectorSell21,100$66.19$1,396,609.00View SEC Filing  
4/5/2016Stuart EssigDirectorSell83,290$66.68$5,553,777.20View SEC Filing  
4/4/2016Stuart EssigDirectorSell42,150$67.26$2,835,009.00View SEC Filing  
5/7/2015Stuart EssigDirectorSell75,000$64.32$4,824,000.00View SEC Filing  
5/6/2015Stuart EssigDirectorSell125,000$64.83$8,103,750.00View SEC Filing  
1/2/2015Judith OgradyVPSell3,500$53.33$186,655.00View SEC Filing  
10/28/2014Stuart EssigDirectorSell147,098$49.58$7,293,118.84View SEC Filing  
10/27/2014Stuart EssigDirectorSell41,268$49.56$2,045,242.08View SEC Filing  
9/2/2014Judith OgradyVPSell2,500$49.82$124,550.00View SEC Filing  
8/27/2014Richard D GorelickVPSell7,000$50.03$350,210.00View SEC Filing  
8/25/2014John B Henneman IIICAOSell20,000$50.12$1,002,400.00View SEC Filing  
8/22/2014Deborah A LeonettiVPSell1,000$50.96$50,960.00View SEC Filing  
8/8/2014Brian LarkinVPSell1,947$48.28$94,001.16View SEC Filing  
7/30/2014Stuart EssigDirectorSell50,800$47.76$2,426,208.00View SEC Filing  
7/23/2014Stuart EssigDirectorSell27,819$47.80$1,329,748.20View SEC Filing  
7/1/2014Judith OgradyVPSell2,500$47.54$118,850.00View SEC Filing  
6/23/2014Stuart EssigDirectorSell21,381$47.76$1,021,156.56View SEC Filing  
4/3/2014Stuart EssigDirectorSell6,344$46.01$291,887.44View SEC Filing  
4/2/2014Stuart EssigDirectorSell76,177$46.05$3,507,950.85View SEC Filing  
3/31/2014Stuart EssigDirectorSell17,479$46.05$804,907.95View SEC Filing  
3/10/2014Deborah LeonettiVPSell7,563$49.22$372,250.86View SEC Filing  
3/4/2014Richard GorelickVPSell2,000$47.98$95,960.00View SEC Filing  
2/28/2014Christian SchadeDirectorSell7,500$47.06$352,950.00View SEC Filing  
2/27/2014Brian LarkinVPSell3,265$46.15$150,679.75View SEC Filing  
2/27/2014John Henneman IIICFOSell5,000$46.07$230,350.00View SEC Filing  
1/16/2014Stuart EssigDirectorSell8,037$49.59$398,554.83View SEC Filing  
1/14/2014Stuart EssigDirectorSell10,600$49.50$524,700.00View SEC Filing  
1/13/2014Stuart EssigDirectorSell99,032$49.51$4,903,074.32View SEC Filing  
1/9/2014Stuart EssigDirectorSell114,431$49.58$5,673,488.98View SEC Filing  
8/30/2013Richard GorelickVPSell3,000$40.79$122,370.00View SEC Filing  
8/23/2013Deborah LeonettiVPSell8,906$41.68$371,202.08View SEC Filing  
8/19/2013Brian LarkinVPSell7,490$41.90$313,831.00View SEC Filing  
8/19/2013John Henneman IIICFOSell30,000$42.08$1,262,400.00View SEC Filing  
8/1/2013Judith OgradyVPSell1,000$39.50$39,500.00View SEC Filing  
7/30/2013Judith OgradyVPSell2,000$38.50$77,000.00View SEC Filing  
5/31/2013Jerry E CorbinVPSell1,876$38.07$71,419.32View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Integra LifeSciences Holdings Corporation (NASDAQ:IART)
DateHeadline
News IconIntegra LifeSciences Holdings Corporation (IART) to Release Earnings on Thursday (NASDAQ:IART)
nyhetsbanken.info - February 24 at 7:05 PM
News IconIntegra LifeSciences Updates 2017 Guidance; Q4 Profit Matches Estimate (NASDAQ:IART)
cloudhostinghq.net - February 24 at 7:05 PM
News IconIntegra LifeSciences Holdings Corporation (IART) Set to Announce Earnings on Thursday (NASDAQ:IART)
prensariotiretail.com - February 24 at 7:05 PM
News IconAnalysts Recommendations: Integra LifeSciences Holdings Corporation (NASDAQ:IART) (NASDAQ:IART)
hoyentv.com - February 24 at 7:05 PM
News IconIntegra LifeSciences Holdings Corporation (NASDAQ:IART) To Report Earnings (NASDAQ:IART)
mundoaguaysaneamiento.net - February 24 at 7:05 PM
capitalcube.com logoIntegra LifeSciences Holdings Corp. :IART-US: Earnings Analysis: Q4, 2016 By the Numbers : February 24, 2017 (NASDAQ:IART)
www.capitalcube.com - February 24 at 7:05 PM
4-traders.com logoINTEGRA LIFESCIENCES HOLDINGS CORP : Completion of Acquisition or Disposition of Assets (form 8-K) (NASDAQ:IART)
www.4-traders.com - February 24 at 10:28 AM
seekingalpha.com logoIntegra LifeSciences Holdings (IART) Q4 2016 Results - Earnings Call Transcript (NASDAQ:IART)
seekingalpha.com - February 24 at 10:28 AM
biz.yahoo.com logoINTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets (NASDAQ:IART)
biz.yahoo.com - February 24 at 10:28 AM
finance.yahoo.com logoEdited Transcript of IART earnings conference call or presentation 23-Feb-17 1:30pm GMT (NASDAQ:IART)
finance.yahoo.com - February 23 at 10:49 PM
us.rd.yahoo.com logoIntegra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance (NASDAQ:IART)
us.rd.yahoo.com - February 23 at 5:48 PM
biz.yahoo.com logoQ4 2016 Integra LifeSciences Holdings Corp Earnings Release - Before Market Open (NASDAQ:IART)
us.rd.yahoo.com - February 23 at 5:48 PM
biz.yahoo.com logoINTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial State (NASDAQ:IART)
us.rd.yahoo.com - February 23 at 5:48 PM
sg.finance.yahoo.com logoIntegra meets 4Q profit forecasts (NASDAQ:IART)
sg.finance.yahoo.com - February 23 at 5:48 PM
biz.yahoo.com logoINTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Financial Statements and Exhibits (NASDAQ:IART)
biz.yahoo.com - February 18 at 5:47 AM
nasdaq.com logoIntegra LifeSciences To Buy J & J Codman Neurosurgery Business For $1.045 Bln (NASDAQ:IART)
www.nasdaq.com - February 16 at 10:43 PM
News IconJohnson & Johnson Offloads a Piece of Its Device Biz to Integra LifeSciences for $1.045 Billion Cash (NASDAQ:IART)
www.biospace.com - February 16 at 5:43 PM
seekingalpha.com logoIntegra LifeSciences (IART) Acquires Johnson & Johnson's (JNJ) Codman Neurosurgery Business - Slideshow (NASDAQ:IART)
seekingalpha.com - February 16 at 5:43 PM
News IconIntegra Lifesciences Holdings Corp (NASDAQ:IART)’s Decision To Buy Codman Neurosurgery Business Is Viewed Positively (NASDAQ:IART)
stockmarketdaily.co - February 16 at 5:43 PM
finance.yahoo.com logoIntegra LifeSciences Plans to Acquire the Codman Neurosurgery Business from Johnson & Johnson for $1.045 Billion in Cash (NASDAQ:IART)
finance.yahoo.com - February 16 at 5:43 PM
finance.yahoo.com logoIntegra offers to buy J&J's Codman neurosurgery business (NASDAQ:IART)
finance.yahoo.com - February 16 at 5:43 PM
marketwatch.com logoIntegra to buy J&J's Codman Neurosurgery business for $1.05 billion (NASDAQ:IART)
www.marketwatch.com - February 16 at 5:43 PM
biz.yahoo.com logoINTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disc (NASDAQ:IART)
biz.yahoo.com - February 16 at 5:43 PM
wsj.com logo[$$] Integra Bids $1.05 Billion for J&J Neurosurgery Business (NASDAQ:IART)
www.wsj.com - February 16 at 5:43 PM
thestreet.com logoIntegra Scoops Up JNJ's Codman Neurosurgery for $1.05 Billion (NASDAQ:IART)
www.thestreet.com - February 16 at 5:43 PM
finance.yahoo.com logoIntegra to buy J&J's Codman neurosurgery business for $1.05 bln (NASDAQ:IART)
finance.yahoo.com - February 16 at 5:43 PM
realistinvestor.com logoIntegra LifeSciences Holdings Corporation (NASDAQ:IART) Is Expected To Post EPS Of $0.61 (NASDAQ:IART)
www.realistinvestor.com - February 11 at 10:55 PM
bizjournals.com logoResearch Reports Initiation on Medical Instruments Stocks -- Waters, Insulet, Integra LifeSciences, and Cooper (NASDAQ:IART)
www.bizjournals.com - February 10 at 6:31 PM
biz.yahoo.com logoINTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statement (NASDAQ:IART)
biz.yahoo.com - February 8 at 6:30 PM
nasdaq.com logoIntegra LifeSciences to Host Its Fourth Quarter 2016 Earnings Results ... (NASDAQ:IART)
www.nasdaq.com - January 27 at 12:28 AM
finance.yahoo.com logoIntegra LifeSciences to Host Its Fourth Quarter 2016 Earnings Results Conference Call on February 23, 2017 (NASDAQ:IART)
finance.yahoo.com - January 26 at 7:28 PM
investingnews.com logoIntegra LifeSciences Commences Previously Announced Cash Tender Offer to Acquire Derma Sciences (NASDAQ:IART)
investingnews.com - January 25 at 7:10 PM
capitalcube.com logoIntegra LifeSciences Holdings Corp. breached its 50 day moving average in a Bullish Manner : IART-US : January 24, 2017 (NASDAQ:IART)
www.capitalcube.com - January 24 at 6:32 PM
finance.yahoo.com logoSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Whether the Sale of Derma Sciences, Inc. to Integra LifeSciences Holdings Corporation for $7 Per Share is Fair to Shareholders -- DSCI (NASDAQ:IART)
finance.yahoo.com - January 17 at 11:56 AM
News IconIntegra LifeSciences Holdings Corporation (IART) Releases FY17 Earnings Guidance (NASDAQ:IART)
vgtoday.net - January 14 at 5:50 PM
biz.yahoo.com logoINTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:IART)
us.rd.yahoo.com - January 12 at 11:19 PM
biz.yahoo.com logoINTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operati (NASDAQ:IART)
us.rd.yahoo.com - January 11 at 6:27 PM
thestreet.com logoDerma Sciences Soars Almost 40% on Buyout by Integra (NASDAQ:IART)
us.rd.yahoo.com - January 11 at 6:27 PM
finance.yahoo.com logo3:17 am Integra releases Q4 and FY17 guidance; sees Q4 and FY17 EPS in-line with consensus (NASDAQ:IART)
finance.yahoo.com - January 11 at 4:47 AM
us.rd.yahoo.com logoIntegra upgraded by JMP Securities (NASDAQ:IART)
us.rd.yahoo.com - January 6 at 11:29 PM
marketexclusive.com logoAnalyst Upgrades – Integra LifeSciences Holdings Corporation (NASDAQ:IART) Stock Gets Upgraded By JMP Securities from Market Perform to Outperform (NASDAQ:IART)
marketexclusive.com - January 6 at 6:26 PM
capitalcube.com logoIntegra LifeSciences Holdings Corp. breached its 50 day moving average in a Bearish Manner : IART-US : January 5, 2017 (NASDAQ:IART)
www.capitalcube.com - January 5 at 7:04 PM
biz.yahoo.com logoSplits Calendar: Integra splits before market open today (2:1 ratio) (NASDAQ:IART)
biz.yahoo.com - January 3 at 11:42 AM
marketexclusive.com logoINTEGRA LIFESCIENCES HOLDINGS CORPORATION (NASDAQ:IART) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (NASDAQ:IART)
marketexclusive.com - December 23 at 11:03 PM
News IconIntegra LifeSciences Holdings Corp. (IART) Shares Bought by First Trust Advisors LP (NASDAQ:IART)
www.xboxonezone.com - December 23 at 11:03 PM
us.rd.yahoo.com logo8:02 am Integra announces approval of two-for-one stock split; effective Jan 3, 2017 (NASDAQ:IART)
us.rd.yahoo.com - December 22 at 6:04 PM
publicnow.com logoIntegra LifeSciences Announces Approval of Two-for-One Stock Split (NASDAQ:IART)
www.publicnow.com - December 22 at 6:04 PM
biz.yahoo.com logoINTEGRA LIFESCIENCES HOLDINGS CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Yea (NASDAQ:IART)
biz.yahoo.com - December 22 at 6:04 PM
finance.yahoo.com logoIntegra LifeSciences to Present at the 35th Annual J.P. Morgan Healthcare Conference in January 2017 (NASDAQ:IART)
finance.yahoo.com - December 20 at 11:11 AM
News IconNext Weeks Broker Price Targets For Integra LifeSciences Holdings Corporation (NASDAQ:IART) (NASDAQ:IART)
diy-home-garden.com - December 14 at 11:31 PM

Social

What is Integra LifeSciences Holdings Corporation's stock symbol?

Integra LifeSciences Holdings Corporation trades on the NASDAQ under the ticker symbol "IART."

When did Integra LifeSciences Holdings Corporation's stock split? How did Integra LifeSciences Holdings Corporation's stock split work?

Shares of Integra LifeSciences Holdings Corporation split before market open on Tuesday, January 3rd 2017. The 2-1 split was announced on Thursday, December 22nd 2016. The newly minted shares were issued to shareholders after the closing bell on Wednesday, December 21st 2016. An investor that had 100 shares of Integra LifeSciences Holdings Corporation stock prior to the split would have 200 shares after the split.

Where is Integra LifeSciences Holdings Corporation's stock going? Where will Integra LifeSciences Holdings Corporation's stock price be in 2017?

10 brokers have issued 1 year price objectives for Integra LifeSciences Holdings Corporation's shares. Their predictions range from $42.00 to $52.50. On average, they anticipate Integra LifeSciences Holdings Corporation's share price to reach $47.06 in the next twelve months.

When will Integra LifeSciences Holdings Corporation announce their earnings?

Integra LifeSciences Holdings Corporation is scheduled to release their next quarterly earnings announcement on Tuesday, April, 25th 2017.

Who owns Integra LifeSciences Holdings Corporation stock?

Integra LifeSciences Holdings Corporation's stock is owned by a variety of of retail and institutional investors. Top institutional investors include FMR LLC (7.07%), Champlain Investment Partners LLC (2.64%), Dimensional Fund Advisors LP (1.14%), State Street Corp (0.92%), Janus Capital Management LLC (0.68%) and Atlanta Capital Management Co. L L C (0.45%). Company insiders that own Integra LifeSciences Holdings Corporation stock include Christian S Schade, Daniel L Reuvers, Glenn Coleman, Joseph Vinhais, Peter J Arduini, Raymond G Murphy, Richard D Gorelick and Stuart Essig.

Who sold Integra LifeSciences Holdings Corporation stock? Who is selling Integra LifeSciences Holdings Corporation stock?

Integra LifeSciences Holdings Corporation's stock was sold by a variety of institutional investors in the last quarter, including Allianz Asset Management AG, Westwood Holdings Group Inc., Loomis Sayles & Co. L P, Federated Investors Inc. PA, Dimensional Fund Advisors LP, Artisan Partners Limited Partnership, Guggenheim Capital LLC and Netols Asset Management Inc.. Company insiders that have sold Integra LifeSciences Holdings Corporation stock in the last year include Christian S Schade, Daniel L Reuvers, Glenn Coleman, Joseph Vinhais, Peter J Arduini, Raymond G Murphy, Richard D Gorelick and Stuart Essig.

Who bought Integra LifeSciences Holdings Corporation stock? Who is buying Integra LifeSciences Holdings Corporation stock?

Integra LifeSciences Holdings Corporation's stock was acquired by a variety of institutional investors in the last quarter, including Janus Capital Management LLC, Champlain Investment Partners LLC, Russell Investments Group Ltd., Two Sigma Investments LP, FMR LLC, State Street Corp, Atlanta Capital Management Co. L L C and Employees Retirement System of Texas.

How do I buy Integra LifeSciences Holdings Corporation stock?

Shares of Integra LifeSciences Holdings Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Integra LifeSciences Holdings Corporation stock cost?

One share of Integra LifeSciences Holdings Corporation stock can currently be purchased for approximately $42.33.

Integra LifeSciences Holdings Corporation (NASDAQ:IART) Chart for Saturday, February, 25, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Earnings History Chart

Earnings by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Dividend History Chart

Dividend Payments by Quarter for Integra LifeSciences Holdings Corporation (NASDAQ:IART)

Last Updated on 2/25/2017 by MarketBeat.com Staff